SBC · NASDAQ · Consulting Services

S.B.C. Medical Group (SBC)

Provides management infrastructure for Shonan Beauty Clinic and adjacent aesthetic-healthcare brands.

$4.21
At close+0.03 (+0.72%)
  1. SBC Medical Group Re-Accelerates Growth as EBITDA Surges 32% in Q2

    MarketBeat

    SBC Medical Group NASDAQ: SBC said its growth re-accelerated in the second quarter of 2026 following structural reforms undertaken in 2025, with profit growth exceeding revenue growth as the company expanded management services revenue and increased service fees.

  2. SBC Medical Group Q2 Growth Re-Accelerates as EBITDA Surges 32%

    MarketBeatEarnings

    SBC Medical Group NASDAQ: SBC said its growth re-accelerated in the second quarter of 2026 as the company completed structural reforms undertaken in 2025, expanded its clinic network and increased management-services revenue.

  3. SBC Medical Group Holdings Incorporated (SBC) Q2 2026 Earnings Call Transcript

    Seeking Alpha

    SBC Medical Group Holdings Incorporated (SBC) Q2 2026 Earnings Call Transcript

  4. SBC Medical Group Q2 Earnings Call Highlights

    MarketBeat

    SBC Medical Group NASDAQ: SBC said its second-quarter 2026 results reflected a reacceleration in growth following structural reforms undertaken in 2025, with adjusted EBITDA rising faster than revenue despite the effect of a weaker yen on reported results.

  5. SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results

    Business Wire

    IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Up 335%, Adjusted EBITDA1 Up 32% Year-over-Year.

  6. SBC Medical to Announce 2Q 2026 Financial Results

    GlobeNewsWire

    IRVINE, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the second quarter ended June 30, 2026, before U.S. market open on August 13, 2026.

  7. SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET

    GlobeNewsWire

    IRVINE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced that Stephen Rodgers, Head of Global Planning and Strategy, and Hikaru Fukui, Head of IR Department, have been invited to present at “Health, Wellness & Longevity,” presented by Maxim Group LLC, on Wednesday, July 22nd at 10:30 a.m.

  8. SBC Medical Group Shareholders Approve Board, Charter Changes at Annual Meeting

    MarketBeat

    SBC Medical Group NASDAQ: SBC held its 2026 annual meeting of stockholders in a virtual format, with Chairman and Chief Executive Officer Yoshiyuki Aikawa presiding over the meeting.

  9. SBC Medical Launches Japan's First Specialized Men's Beard Hair Removal Clinic, Introducing a Scalable, Capital-Efficient Growth Platform

    GlobeNewsWire

    IRVINE, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced the opening of SBC MEN'S FLASH CLINIC Ikebukuro, a clinic dedicated exclusively to men's beard hair removal, in Tokyo on August 6, 2026.

  10. SBC Medical will participate in several upcoming investor conferences in May and June 2026

    Globe News Wire

    IRVINE, Calif. , May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in May and June 2026.

  11. SBC Medical will participate in several upcoming investor conferences in May and June 2026

    GlobeNewsWire

    IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in May and June 2026.

  12. SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok

    GlobeNewsWire

    Japanese-Quality Pico Laser Treatment to Serve the Growing Thai Aesthetic Healthcare Market, with Service Launch Scheduled for June 2026 Japanese-Quality Pico Laser Treatment to Serve the Growing Thai Aesthetic Healthcare Market, with Service Launch Scheduled for June 2026

  13. SBC Medical Group Q1 Earnings Call Highlights

    MarketBeat

    SBC Medical Group NASDAQ: SBC reported first-quarter 2026 revenue of $43 million, down 9% from a year earlier, as management said prior fee structure revisions continued to weigh on reported results even as underlying clinic activity improved.

  14. SBC Medical Group Holdings Announces First Quarter 2026 Financial Results

    GuruFocus

    SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support ac

  15. SBC Medical Group Holdings Announces First Quarter 2026 Financial Results

    Business Wire

    IRVINE, Calif.--(BUSINESS WIRE)-- #1Q--SBC Medical announce to first quarter financial results.

  16. SBC Medical to Announce 1Q 2026 Financial Results

    GlobeNewsWire

    IRVINE, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the first quarter ended March 31, 2026, before U.S. market open on May 14, 2026.

  17. SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

    GlobeNewsWire

    IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced a comprehensive initiative to enhance English-speaking inbound customer support at Shonan Beauty Clinic.

  18. SBC Medical Group (NASDAQ:SBC) and Selectis Health (OTCMKTS:GBCS) Head to Head Analysis

    Defense World

    SBC Medical Group (NASDAQ: SBC - Get Free Report) and Selectis Health (OTCMKTS:GBCS - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Risk and Volatility SBC Medical Group

  19. Analyzing SBC Medical Group (NASDAQ:SBC) and Solventum (NYSE:SOLV)

    Defense World

    SBC Medical Group (NASDAQ: SBC - Get Free Report) and Solventum (NYSE: SOLV - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings. Institutional and Insider Ownership 60.8% of SBC Medical

  20. SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

    Business Wire

    IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the closing of its previously announced underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. The proceeds from the offering to the.